Trial Profile
Assessment of Pharmacokinetics and Bioavailability of Carbon-14 ([14C])-Labelled Oxytocin
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Oxytocin (Primary) ; Oxytocin (Primary)
- Indications Labour disorders
- Focus Pharmacokinetics
- Sponsors Oxytone Bioscience
- 06 Apr 2018 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 12 Apr 2017 New trial record